Want to see HK:2211 full AI Analyst Report?
Universal Health International Group Holding Ltd. (2211) AI Stock Analysis
Universal Health International Group Holding Ltd.
(HKEX:2211)
The overall score is held down primarily by weak underlying financial performance: structurally declining revenue, a return to net losses, and persistently negative operating and free cash flow signal a fragile and cash‑consuming business, despite a conservatively financed balance sheet. Technical factors are a key offset, with the share price trading above its short‑ and medium‑term moving averages, pointing to improving market momentum even as the long‑term trend remains negative. Valuation is only moderately attractive because the negative P/E and absence of a dividend limit fundamental support for the stock, leaving the investment case dependent on a successful operational turnaround and sustained improvement in cash generation.
Universal Health International Group Holding Ltd. (2211) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 39.96M
- Dividend Yield
- ―
- Average Volume (3M)
- 5.40M
- Price to Earnings (P/E)
- -2.2
- Beta (1Y)
- 1.41
- Revenue Growth
- -24.60%
- EPS Growth
- 36.73%
- Country
- Hong Kong
- Employees
- 601
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Pharmaceuticals
Universal Health International Group Holding Ltd. Business Overview & Revenue Model
Company Description
Operating as an investment holding company, Universal Health International Group Holding Limited specializes in the wholesale, retail, and distribution of a comprehensive range of pharmaceutical and healthcare products across China's northeastern reg...
How the Company Makes Money
null
Universal Health International Group Holding Ltd. Financial Statement Overview
Summary
Financial performance is weak overall: revenue is in structural decline with a ~24% drop most recently and another double‑digit fall the year before, profitability has reverted from a small profit in 2024 back to a loss in 2025, and gross margins are modest for the industry, indicating limited pricing power and efficiency. The cash‑flow profile is particularly concerning, with consistently negative operating and free cash flow across all reported years, only modestly improved from the heavy cash burn in 2020, pointing to ongoing cash consumption and elevated liquidity risk. These issues are partly offset by a relatively conservative balance sheet with low and declining leverage, positive equity, and a reasonable capital cushion, which helps solvency but does not resolve the underlying earnings and cash‑flow fragility.
Income Statement
22NegativeBalance Sheet
58NeutralCash Flow
18Very Negative| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 519.49M | 520.69M | 711.51M | 1.09B | 1.30B | 1.27B |
| Gross Profit | 81.13M | 74.57M | 106.49M | 179.88M | 222.60M | 215.32M |
| EBITDA | 6.17M | 6.17M | -11.63M | 12.59M | -70.16M | -160.78M |
| Net Income | -20.44M | -20.49M | -26.01M | 413.00K | -105.40M | -187.65M |
Balance Sheet | ||||||
| Total Assets | 444.06M | 444.06M | 447.60M | 692.88M | 797.10M | 983.55M |
| Cash, Cash Equivalents and Short-Term Investments | 58.87M | 58.87M | 13.40M | 36.92M | 89.37M | 58.63M |
| Total Debt | 47.14M | 47.14M | 25.00M | 70.60M | 40.62M | 40.00M |
| Total Liabilities | 102.73M | 102.73M | 130.03M | 339.99M | 457.57M | 504.47M |
| Stockholders Equity | 341.33M | 341.33M | 317.57M | 352.72M | 314.73M | 408.13M |
Cash Flow | ||||||
| Free Cash Flow | 20.74M | 0 | -59.91M | -101.75M | -19.47M | -47.94M |
| Operating Cash Flow | 20.76M | 0 | -59.84M | -101.73M | -19.40M | -47.81M |
| Investing Cash Flow | 6.26M | 0 | 52.61M | 54.88M | -8.02M | 11.09M |
| Financing Cash Flow | 21.86M | 0 | -6.05M | 40.23M | 11.27M | 55.96M |
Universal Health International Group Holding Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2211, the sentiment is Positive. The current price of 0.46 is above the 20-day moving average (MA) of 0.43, below the 50-day MA of 0.47, and below the 200-day MA of 0.58, indicating a neutral trend. The MACD of -0.01 indicates Negative momentum. The RSI at 52.79 is Neutral, neither overbought nor oversold. The STOCH value of 87.88 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2211.
Universal Health International Group Holding Ltd. Peers Comparison
Overall Rating
HK:215956Neutral
HK:386954Neutral- HK:221153.5Neutral
HK:072242Neutral
HK:213842Neutral
HK:388641Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| HK:2159 | 56Neutral | HKD 528.27M | 9.61 | 28.00% | ― | 91.32% | ― |
| HK:3869 | 54Neutral | HKD 467.79M | -143.32 | -0.41% | ― | 3.16% | -101.02% |
| HK:2211 | 54Neutral | HKD 248.73M | -2.21 | -5.98% | ― | -24.60% | 36.73% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| HK:0722 | 42Neutral | HKD 292.35M | -3.79 | -10.76% | 9.04% | -1.37% | -334.69% |
| HK:2138 | 42Neutral | HKD 645.94M | -1.61 | -25.36% | ― | -8.94% | -140.82% |
| HK:3886 | 41Neutral | HKD 1.10B | 78.09 | 0.48% | 1.10% | -3.26% | ― |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:2211 | Universal Health International Group Holding Ltd. | 0.45 | -0.90 | -66.57% | |
| HK:2138 | EC Healthcare | 0.55 | -0.10 | -16.15% | |
| HK:2159 | Mediwelcome Healthcare Management & Technology Inc. | 1.57 | 0.40 | 34.19% | |
| HK:3869 | Hospital Corporation of China Ltd | 3.38 | -2.61 | -43.49% | |
| HK:3886 | Town Health International Medical Group Ltd. | 0.16 | -0.11 | -40.07% | |
| HK:0722 | UMP Healthcare Holdings Limited | 0.36 | -0.07 | -16.67% |
Universal Health International Group Holding Ltd. Corporate Events
Universal Health Revises Timetable for Capital Reorganisation and Rights Issue
Universal Health International Group Holding Ltd., a Cayman Islands-incorporated healthcare company listed on the Hong Kong Stock Exchange under stock code 2211, is pursuing a capital reorganisation and rights issue to reshape its equity base. The mo...
Universal Health Plans Capital Reorganisation and Major Rights Issue
Universal Health International Group Holding Ltd., a Cayman Islands‑incorporated healthcare company listed in Hong Kong, is reshaping its share capital to strengthen its balance sheet. The firm’s shares, traded under stock code 2211, prov...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Jul 31, 2026